Is the McKinol genetic test reliable, the McKinol gene customer service hotline

There is no question of which is better for real genetic testing. If you advertise yourself as better than someone else's genetic test, be careful.

The main use of genetic testing is for eugenics.

That is, if there is a hereditary disease in the family, genetic testing is required, and when giving birth to offspring, it is necessary to choose not to have children with disease-causing genes, so as to ensure the health of offspring.

At present, the third generation of IVF technology has been able to screen fertilized eggs with genetic diseases. Thus guaranteeing the birth of healthy children.

Now that it is market-oriented, it is purely for your money to do genetic testing for some patients who do not have fertility requirements, and even for ordinary diseases.

Reliable, many major hospitals cooperate

Reliable is the genetic testing company with the most hospital admissions.

The chairman of the board of directors, Wood, graduated from Peking University from 2004 to 2008, and then studied for a master's degree and a doctorate at Columbia University in the United States, during which he participated in the research and development of the world's second-generation gene sequencing.

It is quite reliable, this company develops its own research and testing kits to break the foreign monopoly.

Their detection is still relatively reliable

Unit introduction: Mekino, an excellent brand of sequencing in China, is a company with a patent for the design and manufacture of DNA capture probes in China, with the ability to independently design and produce capture reagents, and can also provide professional capture and sequencing analysis services.

Relying on the Johns Hopkins University Sidney Kimmel Cancer Research Center as a platform, the company is committed to the research and development of the most advanced and stable technology, the introduction of high-throughput analysis technology with independent intellectual property rights into China, applied to personalized gene research, and developed a series of personalized gene capture reagent products that can be applied to research, and strives to promote large-scale genetic research and scientific research applications.

So far, the company has developed capture reagent products suitable for blood system diseases, immune system diseases, nervous system diseases, tumor-related genes, deafness, and ophthalmology-related genes, which can accurately and efficiently complete large-scale genome sequence analysis research and promote the development and application of scientific research.

Mackino has a professional, high-level, high-quality technology and R&D team, most of the employees have doctoral and master's degrees, and have strong project development and scientific research strength. One of the company's core technologies is the use of self-developed high-efficiency gene capture technology for next-generation gene sequence analysis, which enables large-scale genetic research and screening.

This technology can flexibly and efficiently intercept human genes of any size of the masked fragment of the bond ridge, and combined with the next-generation gene sequence analysis technology, it greatly reduces the cost of genomics research, thereby further accelerating the development of personalized scientific research and providing reliable strategies.

Adhering to the corporate mission of serving the society and benefiting human health, Mekinac always adheres to the international most advanced capture technology to provide personalized comprehensive services for the majority of scientific researchers in multiple disciplines, and constantly explores and researches to make unremitting efforts for the scientific application of genetic diagnosis.

Can only do a little reference, genetic testing may be good for the detection of genetic diseases, but the rest of the teammates can only play the role of the first, not necessarily accurate, the current technical level itself has not reached that level, relying on this technology is not as effective as doing a comprehensive physical examination, a lot of tout on the Internet is just a marketing tool.

Whether genetic testing is reliable should be understood from two aspects, one is the accuracy of the test itself. There is some kind of defect in the person's genes, can you accurately identify this defect? This accuracy should be high.

You can imagine that the Human Genome Project accurately measured 3 billion and 80 million base molecules on human DNA, which shows that genetic testing technology has been very mature.

The other issue is actually the clinical coincidence rate of risk **. Quite a lot of diseases are very complex, and genetic testing only reflects one aspect of the problem, although this aspect is important, but after all, it only reflects one aspect, so, as a kind of **, relative to the individual, it cannot be 100% consistent with the clinical results, or even 90% consistent.

For example, in breast cancer, if both BRCA1 and BRCA2 genes are defective, the person has about an 80% chance of developing breast cancer. Or to put it this way, if there are 100 women who have problems with both genes, more than 80 of them will develop breast cancer in the future. That's probably how it has a clinical coincidence rate.

But it's already very valuable. For this kind of malignant tumor, not to mention predicting 80 out of 100, even if 50 predicting it, it is very remarkable. Isn't this the point of saving many lives to help us save many lives?

Zhongyuan Concord Gene is doing it!